This announcement is a separate document:
Actinogen Medical Ltd: ACW FY2024 results, advancing into late-stage trials
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.